Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Biohit Oyj’s Financial Reporting and Annual General Meeting in 2018

Posted on: 08 Dec 17

Biohit Oyj Financial calendar, December 8, 2017 at 4:00 pm local time (EET) 

  • Biohit Oyj will release its financial statements for 2017 on Wednesday 28th of February 2018 at 9:30 am.  
  • The Annual Report, which contains the Financial Statements for 2017 and the Report of the Board of Directors, will be published approximately during week 14.
  • Biohit Oyj’s Annual General Meeting has been planned for Wednesday 25th of April 2018 at 5:00 pm. The Board of Directors will call the General Meeting at a later date.
  • Half year financial report for period January-June (H1) 2018 on Wednesday 22th of August 2018 at 9:30 am.

The published economic reports and other stock exchange releases are available on Biohit's website at The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at


Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.


Last updated on: 11/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.